BSECompany Update2d ago · 23 Sept 2026, 05:24 pm

Intimation of Disclosure

Evexia Lifecare Ltd · 524444

✦ AI SummaryRelated Party

Evexia Lifecare Ltd has received disclosure from Shree Saibaba Exim Private Limited, a promoter group entity, regarding the purchase of 50,33,131 equity shares of Evexia Lifecare Limited. The disclosure is made under Regulation 7(2)(a) of SEBI (Prohibition of Insider Trading) Regulations, 2015 and Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Analysis Scores

Earnings Impact2/10
Growth Catalyst2/10
Governance Concern3/10
Regulatory Risk2/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Evexia Lifecare Ltd - 524444 - Disclosure Under Regulation 7(2)(A) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015 And Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011

Attachments (1)

📄

3551eff6-69a5-4dce-9730-d486cef872dc.pdf

pdf

Download →
View document text
EVEXIA LIFECARE LIMITED (Formerly Known as Kavit Industries Ltd.) Date: September 23, 2026 BSE Limited P.]. Towers, Dalal Street, Fort, Mumbai- 400001 Sub: Disclosure under Regulation 7(2)(a) of SEBI (Prohibition of Insider Trading) Regulations, 2015 Dear Sir/Madam, In accordance with the provisions of Regulation 7(2)(a) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015, the Company has received disclosure on September 23, 2026 from M/s. Shree Saibaba Exim Private Limited, Promoter Group with respect to the purchase of 50,33,131 equity shares of Evexia Lifecare Limited. Please find enclosed herewith necessary disclosure under Regulation 7(2)(a) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015. Please take the same on your record. Thanking you. Yours faithfully, (DIN: 01631093) Encl.: As Above Reg. Off. : Tundav Anjesar Raod, Vill. Tundav, Tal.: Savli, Vadodara - 391 775 Corporate Office : 9th Floor, Galav Chambers, Sayajigunj, Vadodara-390 020. Ph : +91 265 2361100 / 2200 CIN : L23100GJ1990PLC014692 Email : info@evexialifecare.com Web.: www.evexialifecare.com Shree Saibaba Exim Private Limited 9 Floor, Galav Chambers, Opp. Sardar Patel Statute, Sayajigunj, Vadodara — 390020 CIN - U51101GJ2013PTC077088 Email ID - shreesaibabaexim202; ail.com Date: September 23, 2026 Managing Director, EVEXIA LIFECARE LIMITED, Vill : Tundao, Tal: Salvi Vadodara- 391775, Gujarat Scrip Code: 524444 Sub: Disclosure under Regulation 7(2)(a) of SEBI (Prohibition of Insider Trading) Regulations, 2015. Dear Sir/Madam, This is with reference to the purchase of equity shares dated September 23, 2026. This intimation is provided in terms of the provisions of Regulation 7(2)(a) of the SEBI Insider Trading Regulations and all other applicable provisions of Securities and Exchange Board of India Act, 1992 and applicable rules and regulations made thereunder. This letter is intended for the Company’s information and records. Thanking You. ‘uaa \ Yours Faithfully, \ Through Artiben Jayeshbhai Thakkar Director (DIN: 02480296) Encl: As above gerao W |Op 9 umwej| romjo e |obms ds ep |ouj om |yo merj an |eps y/dnq [ yo/i Ba yx |9J )s/d1 a yaIaun e og8 1/ o» mea A yuyox- sa neusj Y7 3sods 92( 2€-06- z029 1ioyrqin ojsip Jysep (snenous 5sdnenou (iae madneno u9)z -ounun rsposn.s[ Newa domwdeuA: SAEXIV TINILaQ TSIN doiudemA: - ]NAETEWOT0£0 aReis :fi«..u flenos._.:us_.h dlow0ja1 ysond-qasisnerop MUHOuap ya3n[enou yezaS ta Ad osyP gadNI po ab smxap SANILN 3Y SPIP qeraoJ Nem @d ‘ VD NI ‘N/AI N BP.9S$ dosieobmsin |msipowo PUIe VUOS gdIsou eobmsinou syeras‘ )giowoj sdapgA ax/w uy sA ed |3oj| qauo e |dnu Je |up P% yAda domoj ayer a)401 )gnup |js oy Je |ray Byojpiu esa/se oojpiuB ssond/p syeras‘ sqeras‘ asiduea meue MEILB djap8a sqexas‘ uys‘ 4M bEILB daiso )0UA2J Y940© ujs‘ q1a8p0J nou/ )ouaaJ uagau mias‘ naas‘ /q e |qauj xajenaa dn8Ws QIqaIs nias‘ }0/0jyaJ dunpa -dyaesa |yrdys se0n( maujS mwouQ“ sdaog suppa &9 (1 2(wau (J‘ 5€ FS Y 1e ar 3qe WAeS yrwyap dY VY NL :IS980ON giow03o 1 |'H6' T |0EETE |naw e g |bnu A TT |'66' ¥ |€-06 - vaaHqss‘ yxond syera 258S syedo syera S'LT9 z029 )9121 )0°298 )9'€86 2029 gea p Jrs 1e 9d (me ‘Snu(“ AEPpOPEIB - E600Z0‘ N(e1eJ LLLVOLZ 6T W9 yneq easseqE 0ZeZ JWH0d ou R 44( ' u ( uqmou fusipas ,y.vpiuB( yabnipnous‘ u_PE.Eu.. diond-pa dIseH WAUROUAP xmu..—mfi pdnous 039( Nonoue[ Aejna NnuqaJ )d0unEps nupas sabnpnou z)1()1( oJs3g1 )d.oy /nuA 01y21 oypiBas uflw ne.flnaflm awwlofl_...Enau )sdaPA )Ada jdoune gnInaa Nonoue[ ynuq3J nu)S Aefna )00U1Eps 1075172( fyuap )24.p6a _..aun o iraena NI a0 . a wavuiub o sp }0X95/q4 sepiuS OUnEP pysenous aXojnp AenAas ,y ) sda sYvI1 y USDIPo paIL 2029 N032; ,,s3nu10as, )11( dalerjs nepiuS 19 N N 1 a qe3a: sadyaiuqe1 d[B03: AEpOPEIR Shree Saibaba Exim Private Limited 9% Floor, Galav Chambers, Opp. Sardar Patel Statute, Sayajigunj, Vadodara — 390020 CIN - U51101GJ2013PTC077088 Email ID - fimflfihn&l&;@;flnfl.wn Date: 23/09/2026 To, To, The Department of Corporate Service, The Board of Directors, BSE Limited, EVEXIA LIFECARE LIMITED, Phiroze Jeejeebhoy Tower, Vill: Tundao, Tal: Salvi Vadodara-391775, Dalal Street, Mumbai-400 001. Gujarat Scrip Code: 524444 Dear Sir/Madam, Subject: Disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 This is with reference to the disclosure enclosed herewith as required to be made upon purchase of shares of Evexia Lifecare Limited under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Kindly take the above information on record. Thanking you, Yours faithfully, Name:SHree Saibaba Exim Privai Through Artiben Jayeshbhai Thakkar Director (DIN: 02480296) CC To: EVEXIA LIFECARE LIMITED (For information and record) Vill : Tundao, Tal: Salvi Vadodara-391775, Gujarat Encl: as above Annexure 1 Disclosures under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) ulatio; 2011 Name of the Target Company (TC) EVEXIA LIFECARE LIMITED Name(s) of the acquirer/Seler and Persons Acting in M/s. Shree Saibaba Exim Private Limited Concert (PAC) with the acquirer/SeHer Whether the acquirer/SeHer belongs to | Yes (Promoter Group) Promoter/Promoter group Name(s) of the Stock Exchange(s) where the shares of | BSE Limited TC are Listed Details of the acquisition / dispeset as follows Number % w.r.t. total % w.r.t. share/voting total diluted capital share/voting wherever capital of applicable(*) the TC (**) Before the acquisition / dispesal under consideration, holding of : ) Shares carrying voting rights 11,49,12,585 6.121% 6.121% b) Shares in the nature of encumbrance (pledge/ lien/ non-disposal undertaking/ others) 0 0.00% 0.00% c) Voting rights (VR) otherwise than by shares 0 0.00% 0.00% d) Warrants/convertible securities/any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) 0 0.00% 0.00% Total (a+b+etd) 11,49,12,585 6.121% 6.121% Details of acquisition/sale a) Shares carrying voting rights acquired/seid 50,33,131 0.268% 0.268% b) VRs acquired/sold otherwise than by shares 0 0.00% 0.00% c) Warrants/convertible securities/any other 0 0.00% 0.00% instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) acquired/sold d) Shares encumbered / invoked/released by the 0 0.00% 0.00% acquirer/seller Total (a+b+ctd) 50,33,131 0.268% 0.268% After the acquisition/sale, holding of: a) Shares carrying voting rights b) Shares encumbered with the acquirer/seller 0 0.00% 0.00% ¢) VRs otherwise than by shares 0 0.00% 0.00% d) Warrants/convertible securities/any ~ other 0 0.00% 0.00% instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) after aequisition/sale Total (at+b+ctd) 11,99,45,716 6.389% 6.389% Mode of a/:qulsmon/sele (e.g. open market / efl'—mafke& Open Market i INH L ym /y e tial m / Hierse-traiter cle.) September 23, 2026 Date of acquisition / sale-ef-shares/—VR—or—date—of receipt-of-intimationof alotment-of shares, whichever is applicable Equity share capital / total voting capital of the TC 187,73,28,995 representing 187,73,28,995 shares before the said acquisition/sale of face value of Re. 1/- each. Equity share capital/ total voting capital of the TC after 187,73,28,995 representing 187,73,28,995 shares the said acquisition/sale of face value of Re. 1/- each. Total diluted share/voting capital of the TC after the 187,73,28,995 representing 187,73,28,995 shares said acquisition/sale of face value of Re. 1/- each. Note: (*)Total share capital/ voting capital to be taken as per the latest filing done by the company to the Stock Exchange under Regulation 31 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (**) Diluted share/voting capital means the total number of sh [Showing first 8,000 characters — download PDF for full document]